ResearcherUniversity of California, San FranciscoNo recent work listed

Claire Johns

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-5638-1370; OpenAlex author ID A5089408940. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001354 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrew H. Ko · 1 shared paper, 2019 · strength 0.11
- Paper Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001354 ↗
Jimmy J. Hwang · 1 shared paper, 2019 · strength 0.11
- Paper Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001354 ↗
Celso L. Diaz · 1 shared paper, 2019 · strength 0.11
- Paper Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001354 ↗
Margaret A. Tempero · 1 shared paper, 2019 · strength 0.11
- Paper Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001354 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.